AMVERSIO

This brand name is authorized in Estonia, Croatia, Lithuania

Active ingredients

The drug AMVERSIO contains one active pharmaceutical ingredient (API):

1 Betaine anhydrous UNII 3SCV180C9W - BETAINE

Betaine is a methyl derivative of glycine first isolated from the juice of sugar beets. Betaine participates in the methionine cycle, which produces vital biomolecules including proteins, hormones, phospholipids, polyamines, and nutrients. Betaine is used as a dietary supplement and has a beneficial effect on the human health. The drug acts as a methyl group donor in the remethylation of homocysteine to methionine. Read about Betaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMVERSIO Oral powder	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AA06	Betaine	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives
Discover more medicines within A16AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1883594
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1094793